181 related articles for article (PubMed ID: 19355988)
1. Novel structural insights into class I and II histone deacetylases.
Ficner R
Curr Top Med Chem; 2009; 9(3):235-40. PubMed ID: 19355988
[TBL] [Abstract][Full Text] [Related]
2. Substrate binding to histone deacetylases as shown by the crystal structure of the HDAC8-substrate complex.
Vannini A; Volpari C; Gallinari P; Jones P; Mattu M; Carfí A; De Francesco R; Steinkühler C; Di Marco S
EMBO Rep; 2007 Sep; 8(9):879-84. PubMed ID: 17721440
[TBL] [Abstract][Full Text] [Related]
3. Structural snapshots of human HDAC8 provide insights into the class I histone deacetylases.
Somoza JR; Skene RJ; Katz BA; Mol C; Ho JD; Jennings AJ; Luong C; Arvai A; Buggy JJ; Chi E; Tang J; Sang BC; Verner E; Wynands R; Leahy EM; Dougan DR; Snell G; Navre M; Knuth MW; Swanson RV; McRee DE; Tari LW
Structure; 2004 Jul; 12(7):1325-34. PubMed ID: 15242608
[TBL] [Abstract][Full Text] [Related]
4. Structure of 'linkerless' hydroxamic acid inhibitor-HDAC8 complex confirms the formation of an isoform-specific subpocket.
Tabackman AA; Frankson R; Marsan ES; Perry K; Cole KE
J Struct Biol; 2016 Sep; 195(3):373-378. PubMed ID: 27374062
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor.
Vannini A; Volpari C; Filocamo G; Casavola EC; Brunetti M; Renzoni D; Chakravarty P; Paolini C; De Francesco R; Gallinari P; Steinkühler C; Di Marco S
Proc Natl Acad Sci U S A; 2004 Oct; 101(42):15064-9. PubMed ID: 15477595
[TBL] [Abstract][Full Text] [Related]
6. Chemical Versatility in Catalysis and Inhibition of the Class IIb Histone Deacetylases.
Christianson DW
Acc Chem Res; 2024 Apr; 57(8):1135-1148. PubMed ID: 38530703
[TBL] [Abstract][Full Text] [Related]
7. Structural and functional analysis of the human HDAC4 catalytic domain reveals a regulatory structural zinc-binding domain.
Bottomley MJ; Lo Surdo P; Di Giovine P; Cirillo A; Scarpelli R; Ferrigno F; Jones P; Neddermann P; De Francesco R; Steinkühler C; Gallinari P; Carfí A
J Biol Chem; 2008 Sep; 283(39):26694-704. PubMed ID: 18614528
[TBL] [Abstract][Full Text] [Related]
8. Structural studies of human histone deacetylase 8 and its site-specific variants complexed with substrate and inhibitors.
Dowling DP; Gantt SL; Gattis SG; Fierke CA; Christianson DW
Biochemistry; 2008 Dec; 47(51):13554-63. PubMed ID: 19053282
[TBL] [Abstract][Full Text] [Related]
9. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
[TBL] [Abstract][Full Text] [Related]
10. Human HDAC7 harbors a class IIa histone deacetylase-specific zinc binding motif and cryptic deacetylase activity.
Schuetz A; Min J; Allali-Hassani A; Schapira M; Shuen M; Loppnau P; Mazitschek R; Kwiatkowski NP; Lewis TA; Maglathin RL; McLean TH; Bochkarev A; Plotnikov AN; Vedadi M; Arrowsmith CH
J Biol Chem; 2008 Apr; 283(17):11355-63. PubMed ID: 18285338
[TBL] [Abstract][Full Text] [Related]
11. Toward selective histone deacetylase inhibitor design: homology modeling, docking studies, and molecular dynamics simulations of human class I histone deacetylases.
Wang DF; Helquist P; Wiech NL; Wiest O
J Med Chem; 2005 Nov; 48(22):6936-47. PubMed ID: 16250652
[TBL] [Abstract][Full Text] [Related]
12. Mutagenesis Study Reveals the Rim of Catalytic Entry Site of HDAC4 and -5 as the Major Binding Surface of SMRT Corepressor.
Kim GS; Jung HE; Kim JS; Lee YC
PLoS One; 2015; 10(7):e0132680. PubMed ID: 26161557
[TBL] [Abstract][Full Text] [Related]
13. Design and evaluation of 'Linkerless' hydroxamic acids as selective HDAC8 inhibitors.
Krennhrubec K; Marshall BL; Hedglin M; Verdin E; Ulrich SM
Bioorg Med Chem Lett; 2007 May; 17(10):2874-8. PubMed ID: 17346959
[TBL] [Abstract][Full Text] [Related]
14. General Base-General Acid Catalysis in Human Histone Deacetylase 8.
Gantt SM; Decroos C; Lee MS; Gullett LE; Bowman CM; Christianson DW; Fierke CA
Biochemistry; 2016 Feb; 55(5):820-32. PubMed ID: 26806311
[TBL] [Abstract][Full Text] [Related]
15. Histone Deacetylase 8: Characterization of Physiological Divalent Metal Catalysis.
Nechay MR; Gallup NM; Morgenstern A; Smith QA; Eberhart ME; Alexandrova AN
J Phys Chem B; 2016 Jul; 120(26):5884-95. PubMed ID: 26996235
[TBL] [Abstract][Full Text] [Related]
16. Structure, mechanism, and inhibition of histone deacetylases and related metalloenzymes.
Lombardi PM; Cole KE; Dowling DP; Christianson DW
Curr Opin Struct Biol; 2011 Dec; 21(6):735-43. PubMed ID: 21872466
[TBL] [Abstract][Full Text] [Related]
17. HDAC8 substrates: Histones and beyond.
Wolfson NA; Pitcairn CA; Fierke CA
Biopolymers; 2013 Feb; 99(2):112-26. PubMed ID: 23175386
[TBL] [Abstract][Full Text] [Related]
18. Restoring histone deacetylase activity by waste product release. A view from molecular mechanics simulations with mammalian HDAC8.
Pietra F
Chem Biodivers; 2015 Apr; 12(4):503-12. PubMed ID: 25879496
[TBL] [Abstract][Full Text] [Related]
19. Structural origin of selectivity in class II-selective histone deacetylase inhibitors.
Estiu G; Greenberg E; Harrison CB; Kwiatkowski NP; Mazitschek R; Bradner JE; Wiest O
J Med Chem; 2008 May; 51(10):2898-906. PubMed ID: 18412327
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation of Histone Deacetylase 8: Structural and Mechanistic Analysis of the Phosphomimetic S39E Mutant.
Welker Leng KR; Castañeda CA; Decroos C; Islam B; Haider SM; Christianson DW; Fierke CA
Biochemistry; 2019 Nov; 58(45):4480-4493. PubMed ID: 31633931
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
